Researchers from the Centers for Disease Control and Prevention (CDC) and FDA undertook a study to determine the most commonly implicated active ingredients responsible for childhood poisonings that required emergency hospitalization in the hope of identifying prevention and intervention strategies. Buprenorphine and clonidine were the most common of 12 active ingredients that were found in 45.0% of these hospitalizations.
Modern Medicine News
To reflect its growing interest in delivery of healthcare services, CVS Caremark will rebrand itself as CVS Health. The company also decided to end tobacco sales one month earlier than previously announced.
The Rhode Island Department of Health recently began tracking the number of prescriptions written for opioid painkillers like OxyContin and Vicodin, according to a report on Rhode Island Public Radio.
The Pennsylvania Department of Drug and Alcohol Programs (DDAP) recently issued guidelines for hospital emergency rooms throughout the state to follow when prescribing opioid painkillers.
In an effort to curb increasing opioid abuse and overdose deaths, the Drug Enforcement Agency has voted to reclassify hydrocodone combination products (HCPs) under the more restrictive category of Schedule II.
FDA Commissioner Margaret A. Hamburg, MD, defended the agency’s approval of the powerful opioid Zohydro ER (hydrocodone bitartrate) extended-release capsules, explaining that its highest dose is no more potent than the highest strengths of the opioid OxyContin ER (oxycodone) extended-release and extended-release morphine, in an FDA blog posted April 29.
Pharmacies that don't use social media will soon go the way of the dinosaur. Here are six tips for making these modalities work for you.
Pharmacists and consumers alike need to educate themselves about the proper use of these products, taken either alone or with Rx medications.
Benzodiazepines and opioid medications have dangerous synergistic effects. The use of both has climbed in the last decade, and so has co-prescription.
A penicillin "allergy" label adversely affects the quantity and quality of healthcare in hospitalized patients, a new study reports.